Telescope Innovations Corp. (CSE:TELI)
0.2400
-0.0050 (-2.04%)
Nov 20, 2026, 3:56 PM EST
Telescope Innovations Earnings Call Transcripts
Fiscal Year 2026
-
SDL systems and DirectInject-LC are gaining commercial traction, with installations, an OEM agreement and licensing opportunities across pharma and clean energy. Management forecasts $14Mโ$15M revenue and cash break-even next year.
-
Physical AI and self-driving labs are transforming chemical and pharmaceutical R&D, enabling faster, more efficient process development and opening new markets. Strong partnerships, recurring revenue, and rapid growth position the company for continued expansion.